We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Imagion Biosystems Limited | ASX:IBX | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.002 | 10.53% | 0.021 | 0.019 | 0.021 | 0.021 | 0.019 | 0.019 | 3,758,756 | 05:10:10 |
From Dec 2019 to Dec 2024
TV Interview CEO Bob Proulx Explains Cancer Diagnostic https://youtu.be/X4HLKyIl6Zo
Manhattan Scientifics (OTC; QB MHTX) announces its former wholly owned sub Imagion Bioscience (ASX:IBX) Receives A$2 million in R&D Tax Incentives from the Australian Government (ATO)
Bob Proulx, Executive Chairman of Imagion Biosystems, said: “We are very pleased to report to our shareholders that the tax incentive funds have been received and that the rebate came in higher than the A$1.7 million we originally expected. This cash infusion will significantly enhance our ability to advance the development of our ground-breaking diagnostic imaging technology which was recently designated by the U.S. Food and Drug Administration as a ‘Breakthrough Device’”.
About Manhattan Scientifics Inc.
Manhattan Scientifics is focused on the commercialization of disruptive technologies
Forward-looking statement:
This press release contains forward looking statements which are subject 5to a number of risks, assumptions and uncertainties. Mgt believes that purchase of our shares should be considered to be at the high end of the risk spectrum.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005680/en/
Marvin Maslow, Chairman: 917.923.3300 Manny Tsoupanarias, CEO : 917.688.4158
1 Year Imagion Biosystems Chart |
1 Month Imagion Biosystems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
